PharmaKonsult Executive Advisory

Cushing's Syndrome and Cushing Disease: Treatment Value Begins with the Correct Diagnosis

For Cushing's syndrome, commercial success depends less on competition than on identifying patients early enough to enter the treatment pathway—diagnosis is the first commercial barrier.

Executive Perspective For organizations investing in Cushing's syndrome, commercial planning typically focuses on clinical differentiation, market access, pricing, physician adoption, and competitive positioning. These are all critical components of a successful launch. However, they all depend on one event that occurs much earlier. A patient must first be correctly diagnosed. Unlike many therapeutic areas where multiple therapies compete for a well-defined patient population, Cushing's syndrome presents a different commercial challenge…

Full article

Full article available by request only.

Contact PharmaKonsult to request the complete opinion paper.

Share this article